107 related articles for article (PubMed ID: 11460208)
1. Human parvovirus B19 infection in HIV-positive patients.
Aguiar FS; Lopes DP; Bazin AR; Setúbal S; Cohen BJ; Nascimento JP
Rev Soc Bras Med Trop; 2001; 34(3):239-42. PubMed ID: 11460208
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus.
van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC
Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068
[TBL] [Abstract][Full Text] [Related]
3. Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV.
Azadmanesh K; Mohraz M; Kazemimanesh M; Aghakhani A; Foroughi M; Banifazl M; Eslamifar A; Ramezani A
J Med Virol; 2015 Jul; 87(7):1124-9. PubMed ID: 25771750
[TBL] [Abstract][Full Text] [Related]
4. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients.
Musiani M; Azzi A; Zerbini M; Gibellini D; Venturoli S; Zakrzewska K; Re MC; Gentilomi G; Gallinella G; La Placa M
J Med Virol; 1993 Jun; 40(2):157-60. PubMed ID: 8395555
[TBL] [Abstract][Full Text] [Related]
5. Parvovirus B19-related anemia in HIV-infected patients.
Koduri PR
AIDS Patient Care STDS; 2000 Jan; 14(1):7-11. PubMed ID: 12240888
[TBL] [Abstract][Full Text] [Related]
6. Primary human parvovirus B19 infection in an HIV infected patient on antiretroviral therapy.
Gadwalkar SR; Deepa DV; Katageri A; Murthy PR; Dhar R
J Assoc Physicians India; 2013 Dec; 61(12):910-2. PubMed ID: 24968551
[TBL] [Abstract][Full Text] [Related]
7. Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients.
Crook TW; Rogers BB; McFarland RD; Kroft SH; Muretto P; Hernandez JA; Latimer MJ; McKenna RW
Hum Pathol; 2000 Feb; 31(2):161-8. PubMed ID: 10685629
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
9. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
Chernak E; Dubin G; Henry D; Naides SJ; Hodinka RL; MacGregor RR; Friedman HM
Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 in bone marrows from adults with acquired immunodeficiency syndrome: a comparative study using in situ hybridization and immunohistochemistry.
Liu W; Ittmann M; Liu J; Schoentag R; Tierno P; Greco MA; Sidhu G; Nierodzik M; Wieczorek R
Hum Pathol; 1997 Jul; 28(7):760-6. PubMed ID: 9224741
[TBL] [Abstract][Full Text] [Related]
11. Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia.
Goedert JJ; Erdman DD; Konkle BA; Török TJ; Lederman MM; Kleinert D; Mandalaki T; Kessler CM; Anderson LJ; Luban NL
Am J Hematol; 1997 Dec; 56(4):248-51. PubMed ID: 9395187
[TBL] [Abstract][Full Text] [Related]
12. Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study.
LaMonte AC; Paul ME; Read JS; Frederick MM; Erdman DD; Han LL; Anderson LJ;
J Infect Dis; 2004 Mar; 189(5):847-51. PubMed ID: 14976602
[TBL] [Abstract][Full Text] [Related]
13. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients.
Chang FY; Singh N; Gayowski T; Marino IR
Clin Transplant; 1996 Jun; 10(3):243-7. PubMed ID: 8826660
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 infections in patients with chronic anemia.
Heegaard ED; Myhre J; Hornsleth A; Gundestrup M; Boye H
Haematologica; 1997; 82(4):402-5. PubMed ID: 9299850
[TBL] [Abstract][Full Text] [Related]
15. Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma.
Koenigbauer UF; Eastlund T; Day JW
Transfusion; 2000 Oct; 40(10):1203-6. PubMed ID: 11061856
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
17. Parvovirus B19 infection after plasma exchange for myasthenia gravis.
Bianchi M; Rago I; Zini G; D'Onofrio G; Leone G
Lab Hematol; 2007; 13(1):34-8. PubMed ID: 17353182
[TBL] [Abstract][Full Text] [Related]
18. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.
Frickhofen N; Abkowitz JL; Safford M; Berry JM; Antunez-de-Mayolo J; Astrow A; Cohen R; Halperin I; King L; Mintzer D
Ann Intern Med; 1990 Dec; 113(12):926-33. PubMed ID: 2173460
[TBL] [Abstract][Full Text] [Related]
19. Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises.
Sant'Anna AL; Garcia Rde C; Marzoche M; da Rocha HH; Paula MT; Lobo CC; Nascimento JP
Rev Inst Med Trop Sao Paulo; 2002; 44(4):187-90. PubMed ID: 12219109
[TBL] [Abstract][Full Text] [Related]
20. A population-based epidemiological survey of human parvovirus B19 infection: a project of the Kyushu and Okinawa Population Study (KOPS).
Ihara T; Furusyo N; Hayashi T; Toyoda K; Murata M; Hayashi J
Arch Virol; 2013 Dec; 158(12):2465-72. PubMed ID: 23775357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
